Please assess the completion status of the following clinical trial:

Trial Title: Effect of Rosuvastatin on Triglyceride Levels in Mexican Hypertriglyceridemic Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients older than 18 years, both genders, without any previous treatment with statins or other lipid lowering drugs for at least 6 months~* With elevated triglycerides above 200 and below 800mg/dl and willing to follow all study procedures including assisting to clinics, fasting before blood samples and signing a written consent~Exclusion Criteria:~* High levels of low-density lipoprotein cholesterol (LDL-C)~* Unstable cardiovascular condition or awaiting a myocardial revascularization~* Congestive cardiac failure~* Uncontrolled diabetes~* Cancer~* Uncontrolled hypothyroidism~* Familial hypercholesterolemia~* Liver/muscle disease~* Pregnancy~* Other

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).